(Q53237147)

12 May 2018

title

Polycomb group protein EZH2 is frequently expressed in inflammatory breast cancer and is predictive of worse clinical outcome (English)

1 reference

inflammatory breast cancer

5 December 2024

main subject

1 reference

6

Naoto T. Ueno

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21713757

5 December 2024

7

Anthony Lucci

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21713757

5 December 2024

author name string

Yun Gong

1

1 reference

12 May 2018

Lei Huo

2

1 reference

12 May 2018

Ping Liu

3

1 reference

12 May 2018

Nour Sneige

4

1 reference

12 May 2018

Xiaoping Sun

5

1 reference

12 May 2018

Vicente Valero

9

1 reference

12 May 2018

Massimo Cristofanilli

10

1 reference

12 May 2018

Thomas A. Buchholz

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21713757

5 December 2024

language of work or name

English

0 references

publication date

28 June 2011

1 reference

12 May 2018

full work available at URL

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.26179

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21713757

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcncr.26179

5 December 2024

1 reference

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.26179/fullpdf

5 December 2024

1 reference

5 December 2024

1 reference

12 May 2018

volume

117

1 reference

12 May 2018

issue

24

1 reference

12 May 2018

page(s)

5476-5484

1 reference

12 May 2018

Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26179

Polycomb complexes repress developmental regulators in murine embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26179

Role of polycomb group proteins in stem cell self-renewal and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26179

Stem cells primed for action: polycomb repressive complexes restrain the expression of lineage-specific regulators in embryonic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26179

Stem cell regulation by polycomb repressors: postponing commitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26179

Concise review: roles of polycomb group proteins in development and disease: a stem cell perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26179

Maintenance of undifferentiated state and self-renewal of embryonic neural stem cells by Polycomb protein Ring1B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26179

Polycomb group genes: keeping stem cell activity in balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26179

Stem cells and cancer; the polycomb connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26179

Expression of enhancer of zeste homologue 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26179

EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26179

Decreased expression of EZH2 is associated with upregulation of ER and favorable outcome to tamoxifen in advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26179

Poorly differentiated breast carcinoma is associated with increased expression of the human polycomb group EZH2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26179

EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26179

Coexpression of BMI-1 and EZH2 polycomb group genes in Reed-Sternberg cells of Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26179

The Polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26179

Expression of the enhancer of zeste homolog 2 is correlated with poor prognosis in human gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26179

Clinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26179

Expression changes in EZH2, but not in BMI-1, SIRT1, DNMT1 or DNMT3B are associated with DNA methylation changes in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26179

The polycomb group protein EZH2 is involved in progression of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26179

Expression of polycomb group protein EZH2 in nevi and melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26179

Increased expression of the polycomb group gene, EZH2, in transitional cell carcinoma of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26179

Downregulation of EZH2 decreases growth of estrogen receptor-negative invasive breast carcinoma and requires BRCA1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26179

EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26179

The Polycomb group protein EZH2 impairs DNA repair in breast epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26179

Enhancer of Zeste 2 as a marker of preneoplastic progression in the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26179

Role of histone H3 lysine 27 methylation in Polycomb-group silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26179

Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26179

Integration of estrogen and Wnt signaling circuits by the polycomb group protein EZH2 in breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26179

Combinatorial pharmacologic approaches target EZH2-mediated gene repression in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26179

The Polycomb group protein Enhancer of Zeste 2: its links to DNA repair and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26179

Activated p53 suppresses the histone methyltransferase EZH2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26179

MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1alpha/HIF-1beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26179

Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26179

MicroRNA-26a targets the histone methyltransferase Enhancer of Zeste homolog 2 during myogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26179

Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26179

Trends for Inflammatory Breast Cancer: Is Survival Improving?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26179

7 January 2021

Inflammatory breast cancer (IBC) and patterns of recurrence: understanding the biology of a unique disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26179

7 January 2021

Polycomb-group oncogenes EZH2, BMI1, and RING1 are overexpressed in prostate cancer with adverse pathologic and clinical features

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26179

7 January 2021

Identification of EZH2 as a molecular marker for a precancerous state in morphologically normal breast tissues

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26179

7 January 2021

Identification of the polycomb group protein SU(Z)12 as a potential molecular target for human cancer therapy

12

1 reference

5 December 2024

Identifiers

DOI

10.1002/CNCR.26179

1 reference

12 May 2018

release_pm3ae7zoqbg7tokpm5ipcmwt6a

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pm3ae7zoqbg7tokpm5ipcmwt6a

24 November 2022

mapped directly with Wikidata item

1 reference

12 May 2018